Mechanical Circulatory Support for Complex High-Risk Indicated Percutaneous Coronary Intervention: Network Meta-Analysis of Randomized Trials.
Kamil Bujak, Claudio Laudani, Daniele Giacoppo et al.
✦ AI-curated · Sources linked
In 30 seconds
This network meta-analysis evaluated the efficacy and safety of mechanical circulatory support (MCS) strategies in patients undergoing complex high-risk indicated percutaneous coronary intervention. Analyzing data from eight randomized trials involving 1856 patients, the study found that while percutaneous left ventricular assist devices and intra-aortic balloon pumps reduced periprocedural major adverse events, no MCS strategy improved major adverse cardiovascular events at 30 days or at a mean follow-up of 10.8 months.
Key findings
- No MCS strategy was associated with lower major adverse cardiovascular events compared to standard care at 30 days.
- Percutaneous left ventricular assist devices reduced periprocedural major adverse events with a risk ratio of 0.30.
- Intra-aortic balloon pump also reduced periprocedural major adverse events with a risk ratio of 0.26.
- At a mean follow-up of 10.8 months, no significant differences in major adverse cardiovascular events were observed among MCS strategies.
Why it matters
Understanding the effectiveness of mechanical circulatory support during high-risk procedures is crucial for optimizing patient outcomes. This study highlights that while some MCS strategies may reduce periprocedural complications, they do not improve long-term cardiovascular outcomes, informing clinical decision-making.